Literature DB >> 30481806

Meibography: A Japanese Perspective.

Reiko Arita1.   

Abstract

Meibography allows observation of meibomian glands in an objective and repeatable manner. Original meibography systems were invasive and not readily adopted by ophthalmology clinics. The development of noncontact infrared meibography allowed the rapid and noninvasive observation of meibomian glands, and such systems have now been widely adopted for standard examinations in dry eye clinics. Noncontact meibography has also spurred research into meibomian glands and has been applied to evaluation of their structure and status in various ocular surface diseases. Although the images obtained by meibography are objective and repeatable, the interpretation of these images is subjective, with the relationship between image features and actual gland structure and composition remaining unclear. Additional clinical and basic research with regard to the interpretation of meibography images is thus necessary. Future improvements to meibography will likely provide new insights into the pathophysiology of meibomian gland diseases as well as enhance its contribution to the diagnosis and evaluation of treatments for such diseases.

Entities:  

Mesh:

Year:  2018        PMID: 30481806     DOI: 10.1167/iovs.17-23631

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Grading reliability of the tear film viscosity examination.

Authors:  Hung-Yin Lai; Po-Chiung Fang; Alexander Chen; Ming-Tse Kuo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-04-24       Impact factor: 3.117

2.  Bevacizumab Eye Drops Vs. Intra-meibomian Gland Injection of Bevacizumab for Meibomian Gland Dysfunction-Associated Posterior Blepharitis.

Authors:  Chitchanok Tantipat; Ngamjit Kasetsuwan; Patraramon Chotikkakamthorn; Krit Pongpirul
Journal:  Front Med (Lausanne)       Date:  2022-06-10

3.  Relationship between meibomian gland loss in infrared meibography and meibum quality in dry eye patients.

Authors:  Minji Ha; Si-Eun Oh; Woong-Joo Whang; Kyung-Sun Na; Eun Chul Kim; Hyun-Seung Kim; Jin Soo Kim; Ho Sik Hwang
Journal:  BMC Ophthalmol       Date:  2022-07-04       Impact factor: 2.086

4.  A Retrospective Data Review Confirms That Topical Preservative-Free Hydrocortisone Improves Inflammation in Dry Eye Disease.

Authors:  Biljana Kuzmanović Elabjer; Leon Marković; Mirjana Bjeloš; Mladen Bušić; Daliborka Miletić; Eva Kos
Journal:  Clin Ophthalmol       Date:  2020-10-30

Review 5.  Candidate Molecular Compounds as Potential Indicators for Meibomian Gland Dysfunction.

Authors:  Kofi Asiedu
Journal:  Front Med (Lausanne)       Date:  2022-05-24

Review 6.  Update on ocular graft-versus-host disease.

Authors:  Sridevi Nair; Murugesan Vanathi; Ritika Mukhija; Radhika Tandon; Sandeep Jain; Yoko Ogawa
Journal:  Indian J Ophthalmol       Date:  2021-05       Impact factor: 1.848

7.  Evaluation of ocular psoriasis with meibography.

Authors:  Funda Kemeriz; Burcu Tugrul; Erdogan Yasar
Journal:  An Bras Dermatol       Date:  2021-11-14       Impact factor: 1.896

8.  A Practical Approach to Severity Classification and Treatment of Dry Eye Disease: A Proposal from the Mexican Dry Eye Disease Expert Panel.

Authors:  Alejandro Rodriguez-Garcia; Alejandro Babayan-Sosa; Arturo Ramirez-Miranda; Concepcion Santa Cruz-Valdes; Everardo Hernandez-Quintela; Julio C Hernandez-Camarena; Nallely Ramos-Betancourt; Regina Velasco-Ramos; Raul E Ruiz-Lozano
Journal:  Clin Ophthalmol       Date:  2022-04-28

9.  Evaluation of the meibomian glands using the tear interferometer wearing orthokeratology lenses.

Authors:  Jiyoung Lee; Gyudeok Hwang; Minji Ha; Hyun-Seung Kim; Kyungdo Han; Kyung-Sun Na
Journal:  BMC Ophthalmol       Date:  2022-03-24       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.